【益方生物：2024年净亏损2.4亿元】益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。

金融界2025-04-25

益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530518630?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-25 19:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2530518630","market":"us","top_or_hot":-1,"title":"【益方生物：2024年净亏损2.4亿元】益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。","media":"金融界","content":"<div>\n<p>益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/04/25191349890727.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【益方生物：2024年净亏损2.4亿元】益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【益方生物：2024年净亏损2.4亿元】益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-25 19:13 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/04/25191349890727.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/04/25191349890727.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688382","symbol_name":"益方生物-U","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/04/25191349890727.shtml","article_id":"2530518630","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530518630","pubTimestamp":1745579600,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688382":"益方生物-U"},"translate_title":"[Yifang Bio: Net loss of 240 million yuan in 2024] Yifang Bio announced that the operating income in 2024 will be 169 million yuan, the net loss attributable to shareholders of listed companies will be 240 million yuan, and the net loss attributable to shareholders of listed companies will be deducted from non-recurring gains and losses The net loss was 250 million yuan, and the loss range decreased compared with the same period last year. The company's profit distribution plan for 2024 is not to distribute cash dividends, bonus shares, or convert capital reserve funds into share capital.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688382":1},"content_text":"益方生物公告，2024年度营业收入1.69亿元，归属于上市公司股东的净亏损为2.4亿元，归属于上市公司股东的扣除非经常性损益的净亏损为2.5亿元，亏损幅度较上年同期均有所减少。公司2024年度利润分配方案为不派发现金红利，不送红股，不以资本公积金转增股本。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530518630","isCrawlerRequest":true}